Why might the world benefit from a healthy mosquito? Professor Shigeto Yoshida, at Jichi Medical University (Tochigi, Japan) believes [MORE]
As an indication of things to come, Qiagen (Venlo, The Netherlands) signed an exclusive agreement with Johns Hopkins [MORE]
It’s not surprising that in searching for genomic individuality, researchers would find pathway-exhibiting cohorts based on age and gender. Still, [MORE]
The goal of a faster, less expensive sequencing-capable of reading an entire genome for $1,000–comes closer every month. Physicist [MORE]
Late last year, the British government funded several new centers of innovative manufacturing, altogether representing about a $100m investment. Among [MORE]
Swiss diagnostic and therapeutic giant, Roche, recently invested more than $181m in Halozyme Therapeutics (San Diego, CA) to develop a [MORE]
Age-hearing loss usually proceeds equally in both ears, but occasionally, greater loss in one happens due to a tumor [MORE]
Researchers found a link-amyloid beta damage-between Down’s Syndrome and Alzheimer’s two decades ago, but now it appears that the [MORE]
The axoloti salamander is the model organism the University of Florida’s McKnight Brain Institute is using to investigate neuronal [MORE]
The H1N1 pandemic may precipitate a fundamental change in the way influenza vaccines are produced. Normally, flu virus for [MORE]
Even the tag “behavioral disorders”-meaning psychiatric diseases-is vague. However, the search is now on to identify protein biomarkers in [MORE]
Besides figuring out new ways to run sequencers (e.g. IBM’s new nanopore approach, in the Nov. 3 Tagline), faster sample [MORE]
In acquiring BRAHMS (Hennigsdorf, Germany) last October, Thermo Fisher Scientific (Waltham, MA) took over marketing of BRAHMS’s blood biomarker [MORE]
In the first proof of principle that somatic cells can be turned into induced pluripotent stem cells (iPSCs) through [MORE]
Beckman Coulter (Fullerton, CA) recently announced that it has combined Agencourt Biosciences and Cogenics to form Beckman Coulter Genomics—a business [MORE]
Leading hospitals in the US-e.g. Johns Hopkins, Cleveland Clinic-are pursuing relationships abroad, in some instances actually establishing hospitals overseas, but [MORE]